MedPath

Randomised controlled trial of a telephone-delivered weight loss intervention for overweight and obese women following treatment for breast cancer (Living Well after Breast Cancer)

Not Applicable
Completed
Conditions
Breast Cancer
Overweight/obesity
Cancer - Breast
Diet and Nutrition - Obesity
Registration Number
ACTRN12612000997853
Lead Sponsor
The University of Queensland
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
160
Inclusion Criteria

Diagnosed with stage I-III breast cancer

Finished primary treatment for breast cancer (i.e., surgery, chemotherapy and/or radiotherapy)

Body Mass Index between 25 and 45 kg/m2

Exclusion Criteria

Diagnosed with ductal carcinoma in situ (DCIS; stage 0) or distant metastases (stage IV)

Contraindications to participating in an unsupervised program – receiving dialysis, mobility issues, planning hip/knee replacement in next six months, taking Warfarin, pregnant, active heart disease, breathing problems, use of weight loss medications, weight loss surgery

Unable to travel to Brisbane to complete study assessments

Not sufficiently fluent in English to complete assessments and
participate in telephone-delivered program

Reporting depression/anxiety/other mental health condition as a current significant problem that would interfere with study participation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
weight loss (% initial body weight) (calibrated digital scales)[6-months (short-term), 12-months (end-of-intervention) and 18-months (maintenance post-intervention)]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath